0
Entasis Therapeutics Holdings Inc. Banner Image

Entasis Therapeutics Holdings Inc. has reached its limit for free report views

Work for Entasis Therapeutics Holdings Inc.? Upgrade Your Profile and unlock all your annual reports.

Entasis Therapeutics Holdings Inc.

  • Ticker ETTX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Entasis Therapeutics Holdings Inc. Logo Image
  • 11-50 Employees
  • Based in Waltham, Massachusetts
Entasis is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel antibacterial products to treat serious infections caused by multidrug-resistant Gram-negative bacteria. Entasis’ pathogen-targeted design platform has produced a pipeline of product candidates, including sulbactam-durlobactam (targeting Acinetobacter baumannii infectionsMore), zoliflodacin (targeting Neisseria gonorrhoeae infections), ETX0282CPDP (targeting Enterobacteriaceae infections) and ETX0462 (targeting Pseudomonas infections).
Entasis Therapeutics Holdings Inc.

Most Recent Annual Report

Entasis Therapeutics Holdings Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Entasis Therapeutics Holdings Inc. has reached its limit for free report views.

Older/Archived Annual Reports